Acuity Spatial Genomics is a new venture focused on opening a new frontier in spatial 3D genomics and multiomic analyses for discovery. The company's technology platform enables the visualization of spatially resolved 3D chromatin architecture in individual cells and cell populations in situ, providing critical context in understanding the complete multiomic picture.

Acuity Spatial Genomics

Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.

COM:ACUITYSPATIALGENOMICS

Acuity Spatial Genomics

Financials Not Available